Signal Advisors Wealth LLC Lowers Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Signal Advisors Wealth LLC reduced its holdings in UnitedHealth Group by 64.5% during Q2, now owning 4,054 shares valued at approximately $1.27 million.
• Analysts have mixed views on UnitedHealth Group, with price targets ranging from $286.00 to $440.00, resulting in a consensus rating of "Moderate Buy" and an average target price of $358.95.
• UnitedHealth Group recently declared a $2.21 per share quarterly dividend, equating to an annual yield of 2.6%, with a payout ratio of 38.30%.

Signal Advisors Wealth LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 64.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,054 shares of the healthcare conglomerate's stock after selling 7,354 shares during the period. Signal Advisors Wealth LLC's holdings in UnitedHealth Group were worth $1,265,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. Bayforest Capital Ltd raised its stake in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares during the last quarter. Copia Wealth Management purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $42,000. IAG Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the first quarter worth about $42,000. Finally, Investment Management Corp VA ADV purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $44,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $1.90 during midday trading on Friday, reaching $336.72. 13,528,738 shares of the company traded hands, compared to its average volume of 13,748,202. The firm's 50 day simple moving average is $295.67 and its two-hundred day simple moving average is $365.19. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market cap of $304.96 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 2.19 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Oppenheimer lowered their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Finally, Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday, September 12th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.